Supplementary Table S2 from Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib–treated Patients with BRAFV600-mutated Metastatic Melanoma

Authors :: Antoni Ribas
Grant A. McArthur
Isabelle Rooney
Ivor Caro
Ilsung Chang
Jessie J. Hsu
Hartmut Koeppen
Zhen Shi
Jeffrey A. Sosman
Paul B. Chapman
Claus Garbe
Michele Maio
Brigitte Dréno
Paolo A. Ascierto
James Larkin
Caroline Robert
Matthew J. Wongchenko
Yibing Yan
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Table S2 from Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib–treated Patients with BRAFV600-mutated Metastatic Melanoma

Full Text Access

Tools